부산대학교 도서관

Aim: Tenascin‐C (TNC), a non‐structural extracellular matrix glycoprotein, is transiently expressed during development or after injury, playing an important role in injury and repair process. The potential role of TNC in the pathogenesis of IgA nephropathy (IgAN) remains to be clarified. Methods: Immunohistochemistry staining for TNC was conducted on paraffin‐embedded slices from renal biopsies of 107 IgAN patients, and correlation analysis was made between mesangial TNC expression and clinic‐pathological parameters. In situ hybridization for TNC mRNA was further performed to figure out the cells that express TNC within glomeruli. In vitro experiments were also carried out on mouse mesangial cells (SV40 MES13) to elucidate the effect of TNC on mesangial cells. Results: TNC was expressed in the mesangial area of IgAN, as well as in fibrotic regions. Correlation analysis showed that higher mesangial TNC was associated with higher level of proteinuria, lower estimated glomerular filtration rate and more serious pathological lesions (MEST score). In situ hybridization revealed that abundant TNC mRNA expression was observed in the affected glomeruli of IgAN, but not in minimal change disease. Moreover, TNC mRNA co‐localized with PDGFRβ mRNA, but not with PODXL mRNA, suggesting that TNC mRNA was expressed in the mesangial cells within glomeruli in IgAN. In vitro experiments showed that exogenous TNC promoted matrix protein production and mesangial cell proliferation, which was attenuated by an epidermal growth factor receptor inhibitor. Conclusion: Taken together, these results suggest that mesangial cell‐derived TNC contributes to mesangial matrix expansion and mesangial cell proliferation, which is a potential therapeutic target in IgAN. SUMMARY AT A GLANCE: EP‐2021‐0827.R2 – The pathogenesis of IgA nephropathy remains incompletely understood. Extracellular matrix proteins, such as tenascin‐C, may play an active role in promoting fibrosis and hence affect disease progression. The authors found that mesangial cell‐derived tenascin‐C contributes to mesangial matrix expansion and mesangial cell proliferation, which can be a potential therapeutic target. [ABSTRACT FROM AUTHOR]